Pharmafile Logo
Pharmafocus logo
Advanced Search
cannabis-2152604_960_720

Australian firm Althea enters UK medicinal cannabis market

February 13, 2019
Research and Development Epidiolex, GW Pharma, Medical marijuana, NHS, UK, cannabis

Melbourne-based medicinal cannabis company Althea has become one of the first companies to enter the UK market after the British …

News
janssen_latest_logo_on_sign_closer

Janssen’s esketamine drug recommended by FDA panel for depression

February 13, 2019
Research and Development, Sales and Marketing FDA, Janssen, Spravato, depression, esketamine, major depressive disorder, pharma

In a rare and welcomed development in the treatment of major depressive disorder (MDD), Janssen has announced that its esketamine …

News
101817_tumorsmyeloidsuppressorcells

Researchers find new type of cell membrane which causes cancer cells to explode

February 13, 2019
Research and Development Cancer, FTY720, cell membranes, molecules, oncology

Researchers at the Medical University of South Carolina (MUSC) have discovered a new type of cell membrane complex which causes …

News
image_credit_-_rafael_matsunaga

Clinigen shares soar after $210m Novartis cancer drug deal

February 13, 2019
Research and Development Cancer, Clinigen, Novartis, Proleukin, UK, US, oncology

British company Clinigen has bought the rights to sell Novartis’ cancer drug Proleukin in the United States in a deal …

News
dr_nathwani_770x510

Sanofi name current CMO Dr Ameet Nathwani as new Chief Digital Officer

February 12, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

French firm Sanofi has appointed pharma veteran Dr Ameet Nathwani to the position of Chief Digital Officer. In his new …

Appointment
scotland

Gilead’s CAR-T therapy Yescarta rejected for NHS use in Scotland

February 12, 2019
Manufacturing and Production, Sales and Marketing CAR-T, Cancer, Gilead, NHS, Scotland, Yescarta, kite pharma

It’s bad news for Scottish patients living with aggressive forms of non-Hodgkin lymphoma (NHL) as it emerges that the Scottish …

News
guernsey-1881254_960_720

Immuno Biotech financial chief found guilty of money laundering

February 12, 2019
Manufacturing and Production David Noakes, Dawson-Ball, GcMAF, Guernsey, Immuno Biotech

Peter Edward Dawson-Ball, the financial head of the Guernsey-based firm immuno Biotech, that sold unlicensed blood product GcMAF, has been …

News
merck-keytruda

Keytruda + Inlyta combo beats Pfizer’s chemotherapy Sutent in renal cell carcinoma

February 12, 2019
Manufacturing and Production, Research and Development Cancer, MSD, Pfizer, inlyta, keytruda, pharma, renal cell carcinoma

New data has been revealed on the efficacy of MSD’s Keytruda (pembrolizumab) in combination with Pfizer’s Inlyta (axitinib), showing it …

News
5204602349_c87b204860_z

FDA to crack down on dietary supplements

February 12, 2019
Manufacturing and Production Alzheimer's, Alzheimers, Cancer, Dietary Supplements, FDA, USA, diabetes

The FDA is cracking down on those selling ‘dietary supplements’, having sent warning letters to companies who claim, without proof, …

News
gilead-sciences

Gilead shares drop 4% after failure of NASH drug to meet primary endpoint

February 12, 2019
Manufacturing and Production Gilead, Shares, fatty liver disease, nash, selonsertib

Gilead’s treatment for the progressive fatty liver disease, NASH, has failed to meet its primary goal in a phase 3 …

News
ai_pharmafocus

Solving the drug development problem

February 11, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, drug discovery, feature, pharma, pistoia alliance

Excitement is building for the potential of AI in just about every field, but how can it address pharma’s unique …

Feature
vertex-headquarters

Vertex doubles Q4 profits, angering cystic fibrosis drug advocates in UK

February 11, 2019
Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma

Despite ongoing controversy surrounding the currently stalled negotiations between Vertex and the NHS to make its cystic fibrosis (CF) drug …

News
macaque-3714104_960_720

Scientists identify alcoholism gene

February 11, 2019
Research and Development, Sales and Marketing Alcohol misuse, alcoholism, ethanol, oregon, research

Scientists at the Oregon Health & Science University (OSHU) in Portland have identified a gene which may play a fundamental …

News

UCB teams up with charity to beat treatment-resistant epilepsy in $2.5m partnership

February 11, 2019
Research and Development, Sales and Marketing Epilepsy Society, UCB Pharma, epilepsy, pharma

Belgian firm UCB Pharma has announced a new partnership with the charity Epilepsy Society which will see the pair invest …

News
mosquito-1016254_1280

Diet drugs supress appetite in mosquitoes, study shows

February 11, 2019
Sales and Marketing Zika, dengue, infectuous diseases, malaria, mosquitoes

Scientists were able to supress mosquitoes appetites using diet drugs for humans, according to research published in the journal Cell. …

News

33% of antibiotics prescribed by NHS are given without associated diagnosis, England’s Chief Medical Officer warns

February 11, 2019
Sales and Marketing AMR, Antibiotics, Dame Sally Davies, England, UK, pharma

A third of the antibiotics prescribed by the NHS are given out despite there being no medical evidence that they …

News

Dame Sally Davis to step down as England’s CMO to become Master of Trinity College, Cambridge

February 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Professor Dame Sally Davies is set to step down from her roles as England’s Chief Medical Officer and as the …

Appointment

Researchers develop new, more effective method for detection of HIV virus genomes

February 8, 2019
Medical Communications, Research and Development HIV, University of Texas, pharma

A team of researchers have devised a new way to accurately detect residual HIV in the body’s immune cells, allowing …

News
pat_smallcombe

Pat Smallcombe appointed chairman of J&J Consumer, EMEA

February 8, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Johnson & Johnson Consumer has appointed Pat Smallcombe to the position of Company Group Chairman, Europe, Middle East, Africa (EMEA). …

Appointment
shutterstock_3

FDA warns over breast implant cancer risk after nine deaths confirmed

February 8, 2019
Medical Communications, Research and Development Cancer, FDA, breast implants, pharma

The FDA has warned against the link between breast implants and anaplastic large cell lymphoma, noting that at least nine …

News
The Gateway to Local Adoption Series

Latest content

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development US

January 29, 2026

Five Facts about spinal muscular atrophy

January 28, 2026